Generation of an induced pluripotent stem cell line (MUSIi014-A) from an affected member of a family with autosomal dominant diabetes carrying p.L475P mutation in ZYG11A gene associated with a cell cycle arrest in beta-cell

Stem Cell Res. 2022 Apr:60:102715. doi: 10.1016/j.scr.2022.102715. Epub 2022 Feb 16.

Abstract

A heterozygous mutation (c.T1424C: p.L475P) in ZYG11A completely segregating with hyperglycemia in a Thai family with familial diabetes of the adulthood has been reported as a cause of cell cycle arrest in 1.1B4 cell line. This mutation is a suggestive cause of failure in adaptive beta-cell expansion which, thereby, contributes to the development of diabetes in the family. Here, an induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells (PBMCs) of an affected family member carrying the mutation was generated using Sendai viral reprogramming. The established iPSC line is characterized and confirmed for pluripotency and chromosomal integrity.

Keywords: Autosomal dominant diabetes; Familial diabetes of the adulthood; ZYG11A; iPSC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Cycle Checkpoints
  • Cell Cycle Proteins / genetics
  • Diabetes Mellitus, Type 2* / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Leukocytes, Mononuclear
  • Mutation / genetics

Substances

  • Cell Cycle Proteins
  • ZYG11A protein, human

Supplementary concepts

  • Mason-Type Diabetes